Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis) (Q28187108)
Jump to navigation
Jump to search
scientific article (publication date: August 2001)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis) |
scientific article (publication date: August 2001) |
Statements
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis) (English)
0 references
August 2001
0 references
142
0 references
2
0 references
237-43
0 references